Batilona, Nilo T.
HRN: 23-01-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/08/2023
05/15/2023
IV
2.25
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose WrongDose
Overall appropriateness: No Wrong Dose